Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer von Zweifel, M., Jayson, G.C., Reed, N.S., Osborne, R., Hassan, B., Ledermann, J., Shreeves, G., Poupard, L., Lu, S.-P., Balkissoon, J., Chaplin, D.J., Rustin, G.J.S.

Volltext

A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer von Rustin, G J, Shreeves, G, Nathan, P D, Gaya, A, Ganesan, T S, Wang, D, Boxall, J, Poupard, L, Chaplin, D J, Stratford, M R L, Balkissoon, J, Zweifel, M

Volltext

Phase Ib/II trial of NC-6004 (nanoparticle cisplatin) plus gemcitabine (G) in patients (pts) with advanced solid tumors von Subbiah, V, Combest, A, Grilley-Olson, J, Sharma, N, Andrews, E, Bobe, I, Balkissoon, J, Camp, A, Masada, A, Reitsma, D, Bazhenova, L

Volltext

359 - Phase Ib/II trial of NC-6004 (nanoparticle cisplatin) plus gemcitabine (G) in patients (pts) with advanced solid tumors von Subbiah, V., Combest, A., Grilley-Olson, J., Sharma, N., Andrews, E., Bobe, I., Balkissoon, J., Camp, A., Masada, A., Reitsma, D., Bazhenova, L.

Volltext

Phase Ib/II trial of NC-6004 (nanoparticle cisplatin) plus gemcitabine (G) in pts with advanced solid tumors von Subbiah, V., Combest, A., Griley-Olsen, J., Sharma, N., Andrews, E., Bobe, I., Balkissoon, J., Camp, A., Masada, A., Reitsma, D., Bazhenova, L.

Volltext

P1.03-044 Exploratory Analysis of Lung Cancer Patients in a Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) plus Gemcitabine von Bazhenova, L., Tran, R., Grilley-Olson, J., Sharma, N., Combest, A., Bobe, I., Osada, A., Takahasi, K., Balkissoon, J., Camp, A., Masada, A., Reitsma, D., Subbiah, V.

Volltext

467 Updated efficacy and safety results for a randomized phase 2 trial of a tumor vascular disrupting agent fosbretabulin tromethamine (CA4P) with carboplatin (C), paclitaxel (P) a... von Garon, E.B, Neidhart, J, Neidhart, J.D, Kabbinavar, F, Gabrail, N, de Oliveira, M. Ribeiro, Lu, S.P, Balkissoon, J

Volltext

380 Phase I trial of OXi4503: positron emission tomography (PET) analysis shows early effects on tumour perfusion that predict metabolic response von Price, P, Asselin, M.C, Kotz, B, Charnley, N, Watkins, G, Rustin, G.J.S, Balkissoon, J, Goldberg, Z, Office, C. Drug Development, Saleem, A

Volltext

A randomized phase II trial of a vascular disrupting agent (VDA) fosbretabulin tromethamine (CA4P) with carboplatin (C), paclitaxel (P), and bevacizumab (B) in stage 3B/4 nonsquamo... von Garon, E. B., Kabbinavar, F. F., Neidhart, J. A., Neidhart, J. D., Gabrail, N. Y., Oliveira, M. R., Lu, S., Balkissoon, J.

Volltext

Randomized phase II trial of a tumor vascular disrupting agent fosbretabulin tromethamine (CA4P) with carboplatin (C), paclitaxel (P), and bevacizumab (B) in stage IIIb/IV nonsquam... von Garon, E. B., Kabbinavar, F. F., Neidhart, J. A., Neidhart, J. D., Gabrail, N. Y., Oliveira, M. R., Lu, S. P., Balkissoon, J.

Volltext

SABRE-B: a randomized phase II trial evaluating the safety and efficacy of combining sunitinib (S) with paclitaxel (P) + bevacizumab (B) as first-line treatment for HER2-negative m... von Mayer, E, Kozloff, M, Qamar, R, Klencke, B, Balkissoon, J, Parmar, H, Samant, M, Burstein, HJ

Volltext

Madeleine's death von Balkissoon, E J

Volltext

Lymphatic mapping for staging of head and neck cancer von Balkissoon, Jai, Rasgon, Barry M, Schweitzer, Laurie

Volltext

A randomized phase II/III trial of a tumor vascular disrupting agent fosbretabulin tromethamine (CA4P) with carboplatin (C) and paclitaxel (P) in anaplastic thyroid cancer (ATC): F... von Sosa, J. A., Elisei, R., Jarzab, B., Bal, C. S., Koussis, H., Gramza, A. W., Ben-Yosef, R., Gitlitz, B. J., Haugen, B., Karandikar, S. M., Khuri, F. R., Licitra, L. F., Remick, S. C., Marur, S., Lu, C., Ondrey, F. G., Lu, S., Balkissoon, J.

Volltext

Combretastatin A-4 phosphate (CA4P) carboplatin and paclitaxel in patients with platinum-resistant ovarian cancer: Final phase II trial results von Zweifel, M., Jayson, G., Reed, N., Osborne, R., Hassan, B., Shreeves, G., Poupard, L., Walicke, P. A., Balkissoon, J., Chaplin, D., Rustin, G.

Volltext

A Phase lb trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer von RUSTIN, G. J, SHREEVES, G, BALKISSOON, J. J, ZWEIFEL, M, NATHAN, P. D, GAYA, A, GANESAN, T. S, WANG, D, BOXALL, J, POUPARD, L, CHAPLIN, D. J, STRATFORD, Mrl

Volltext

Phase I Trial of Recombinant Human Macrophage Colony-Stimulating Factor Administered by Continuous Intravenous Infusion in Patients With Metastatic Cancer von Cole, D. J., Sanda, M. G., Yang, J. C., Schwartzentruber, D. J., Weber, J., Ettinghausen, S. E., Pockaj, B. A., Kim, H. I., Levin, R. D., Pogrebniak, H. W., Balkissoon, J., Fenton, R. M., DeBarge, L. R., Kaye, J., Rosenberg, S. A., Parkinson, D. R.

Volltext

Massive upper gastrointestinal bleeding in a patient with a duodenal diverticulum : a case report and review of the literature von BALKISSOON, J, BALKISSOON, B, LEFFALL, L. D, POSEY, D. A

Volltext

Vascular access in the cancer patient von DeWitty, Jr, R L, Siram, S M, Balkissoon, J

Volltext

HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy von MARINCOLA, F. M, VENZON, D, WHITE, D, RUBIN, J. T, LOTZE, M. T, SIMONIS, T. B, BALKISSOON, J, ROSENBERG, S. A, PARKINSON, D. R

Volltext